SCHEMBL8429930

SCHEMBL8429930

CCCCC(C)ON1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.30
MAPK1 P28482 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8429938 0.98 HRH3 (0.32) HRH3L3MBTL1TLR7
SCHEMBL8702181 0.79 ALDH1A1 (0.32) L3MBTL1MEN1KMT2A
SCHEMBL8431381 0.78 HRH3 (0.33) HRH3L3MBTL1MEN1KMT2ATDP1
SCHEMBL15364814 0.76 ALDH1A1 (0.33)
SCHEMBL8431255 0.76 PRKCA (0.31) HRH3TDP1
SCHEMBL9038759 0.76 L3MBTL1 (0.36) HRH3L3MBTL1MEN1KMT2ATDP1
SCHEMBL3305755 0.73 HRH3 (0.39) HRH3L3MBTL1MEN1KMT2ATDP1
SCHEMBL8680858 0.72 FAAH (0.39) L3MBTL1MEN1KMT2ATDP1MAPT
SCHEMBL3307533 0.71 HRH3 (0.36) HRH3L3MBTL1MAPTMAPK1NPSR1
SCHEMBL8683180 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958817-A1 COMPOSITION CONTAINING DIARYLALKANE DERIVATIVE AS THE ACTIVE INGREDIENT FOR TREATING OR PREVENTING PANCREATITIS SANKYO COMPANY LIMITED (JP) 1999-11-24 EP disclosed
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed